Global Infertility Treatment Market Size By Type (Men, Women), By Application (Fertility Clinics, Cryobanks), By Region, And Segment Forecasts, 2023 to 2032

The Global Infertility Treatment Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.5 billion by 2031, growing at a CAGR of 9.5% during the forecast period of 2023-2031. The market is driven by the increasing prevalence of infertility worldwide, rising awareness about reproductive health, and advancements in assisted reproductive technologies (ART). The growing acceptance of in-vitro fertilization (IVF), intrauterine insemination (IUI), and other infertility treatments, along with government initiatives to support fertility treatments, are fueling market growth.

Market Drivers:

Rising Prevalence of Infertility:

The growing incidence of infertility among both men and women due to lifestyle factors, environmental influences, and medical conditions is driving the demand for infertility treatments.

Technological Advancements in Assisted Reproductive Technology (ART):

Innovations such as time-lapse imaging, cryopreservation, and genetic screening are enhancing the success rates of infertility treatments, making them more accessible and effective.

Increasing Awareness and Acceptance of Fertility Treatments:

Changing societal perspectives, increasing awareness campaigns, and financial assistance programs for infertility treatments are encouraging more couples to seek medical help.

Market Restraints:

High Cost of Infertility Treatments:

The significant cost of ART procedures, including IVF and egg freezing, can limit access, particularly in low-income regions.

Ethical and Legal Concerns:

Infertility treatments, especially third-party reproductive options such as surrogacy and egg donation, are subject to varying legal and ethical restrictions across countries.

Side Effects and Risks Associated with Treatment:

The use of hormonal drugs, ovarian hyperstimulation syndrome (OHSS), and multiple pregnancies pose potential health risks to patients undergoing infertility treatments.

Market Opportunities:

Expansion in Emerging Markets:

The rising middle-class population and increasing medical tourism in regions like Asia-Pacific and Latin America present lucrative opportunities for infertility treatment providers.

Advancements in Personalized Medicine and AI in ART:

The integration of artificial intelligence (AI) and personalized medicine in infertility treatment is improving treatment success rates and optimizing patient care.

Rising Investments and Collaborations in Fertility Clinics:

The fertility sector is witnessing increased investments from private healthcare providers, insurance companies, and technology firms, driving market expansion.

Market by Treatment Type Insights:

Assisted Reproductive Technology (ART): This segment holds the largest market share due to the rising preference for IVF, ICSI, and surrogacy.

Medications for Fertility Enhancement: Growing demand for hormone-based treatments and ovarian stimulation drugs.

Surgical Procedures: Corrective surgeries such as laparoscopy and hysteroscopy play a significant role in addressing physical fertility barriers.

Market by End-use Insights:

Fertility Clinics & IVF Centers: Account for the largest share, driven by the increasing number of ART cycles performed globally.

Hospitals & Surgical Centers: Growing integration of fertility treatments in multi-specialty hospitals.

Cryobanks: Witnessing growth due to the rising demand for egg, sperm, and embryo freezing services.

Market by Regional Insights:

North America dominates the market, supported by a strong healthcare infrastructure, insurance coverage for fertility treatments, and high ART adoption rates.

Europe follows closely, with well-established fertility regulations and high awareness about reproductive health.

Asia-Pacific is expected to grow at the fastest rate, driven by rising infertility rates, increasing medical tourism, and expanding healthcare facilities.

Latin America & Middle East & Africa are experiencing growing demand for fertility treatments due to improved healthcare access.

Competitive Scenario:

Major players in the Global Infertility Treatment Market include:

CooperSurgical Inc.

Vitrolife AB

Merck KGaA

Ferring Pharmaceuticals

Thermo Fisher Scientific Inc.

Irvine Scientific

Genea Limited

EMD Serono, Inc.

Progyny, Inc.

Boston IVF

Key companies are focusing on product innovation, partnerships with fertility clinics, and strategic acquisitions to strengthen their market presence.

Scope of Work – Global Infertility Treatment Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.5 billion

CAGR (2023-2031) 9.5%

Key Segments by Treatment Type ART, Medications, Surgical Procedures

Key Segments by End-use Fertility Clinics, Hospitals, Cryobanks

Leading Region North America

Key Players CooperSurgical, Merck KGaA, Vitrolife, Thermo Fisher, Ferring Pharmaceuticals

Key Market Developments

March 2023: Merck KGaA introduced a next-generation IVF stimulation protocol to improve patient outcomes.

June 2023: Vitrolife AB expanded its fertility preservation portfolio by acquiring a leading cryopreservation technology company.

August 2023: Progyny, Inc. partnered with major employers to enhance insurance coverage for infertility treatments in the U.S.

October 2023: CooperSurgical launched an AI-powered embryo selection tool to enhance IVF success rates.

FAQs

What is the current market size of the Global Infertility Treatment Market?

The market was valued at USD 1.2 billion in 2023 and is expected to grow significantly by 2031.

What is the major growth driver of the Global Infertility Treatment Market?

The rising prevalence of infertility, coupled with advancements in ART technologies, is driving market growth.

Which is the largest region during the forecast period in the Global Infertility Treatment Market?

North America dominates due to its advanced healthcare system and increasing ART adoption rates.

Which segment accounted for the largest market share in the Global Infertility Treatment Market?

Assisted Reproductive Technology (ART), including IVF and ICSI, holds the largest market share.

Who are the key market players in the Global Infertility Treatment Market?

Major players include CooperSurgical, Merck KGaA, Vitrolife AB, Ferring Pharmaceuticals, and Thermo Fisher Scientific.

This structured and comprehensive Global Infertility Treatment Market Report provides detailed insights into industry trends, key drivers, competitive landscape, and future growth opportunities.